Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline prophylaxis pharmacokinetic study in CABG surgery
2017-002508-29Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ceftaroline fosamil in bacterial disease, skin and soft tissue infections (SSTIs) and community-acquired pneumonia (CAP), sponsored by Medical University of Vienna. Primary endpoint: Perioperative pharmacokinetic profiles of ceftaroline in plasma, subcutaneous tissue and lung parenchyma. Started Dec 2017; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
bacterial diseaseskin and soft tissue infections (SSTIs)community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on 2017-002508-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002508-29.